OpenAlex
PricingAboutJobs
Log inGet started
Work

Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss

HTML

Year: 2009
Type: review
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2008.00970.x
Authors: S. Jacob, M. Rabbia, M. K. Meier, J. Hauptman
Institution: F. Hoffmann-La Roche AG
Language: English

Topic: Pharmacology and Obesity Treatment
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: orlistat, type 2 diabetes, glycemic control, fasting blood glucose, HbA1c, lipase inhibitors, obesity, overweight, weight loss, obesity treatment, pooled analysis, body mass index, drug safety and tolerability, adverse events, serious adverse events
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1988187729
FWCI: 0.508
Cites: 53
Cited by: 78
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security